Vanguard Group
EVGN icon

Vanguard Group’s Evogene EVGN Stock Holding History

Vanguard Group’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,352
Closed -$116K – 4173
2019
Q1 		$116K Sell
6,352
-50,842
-89% -$1.08M ﹤0.01% 4001
2018
Q4 		$1.13M Buy
57,194
+5,785
+11% +$146K ﹤0.01% 3532
2018
Q3 		$1.6M Buy
51,409
+5,082
+11% +$147K ﹤0.01% 3599
2018
Q2 		$1.32M Hold
46,327
– – ﹤0.01% 3615
2018
Q1 		$1.47M Buy
46,327
+2,719
+6% +$101K ﹤0.01% 3554
2017
Q4 		$1.61M Hold
43,608
– – ﹤0.01% 3492
2017
Q3 		$1.94M Sell
43,608
-15
-0% -$714 ﹤0.01% 3409
2017
Q2 		$2.44M Buy
43,623
+1,740
+4% +$89.9K ﹤0.01% 3327
2017
Q1 		$2.24M Buy
41,883
+1,696
+4% +$88.3K ﹤0.01% 3351
2016
Q4 		$2.05M Hold
40,187
– – ﹤0.01% 3353
2016
Q3 		$2.56M Buy
40,187
+1,972
+5% +$130K ﹤0.01% 3300
2016
Q2 		$2.38M Buy
38,215
+4,994
+15% +$348K ﹤0.01% 3316
2016
Q1 		$2.16M Buy
33,221
+4,018
+14% +$276K ﹤0.01% 3342
2015
Q4 		$2.35M Buy
29,203
+3,295
+13% +$245K ﹤0.01% 3328
2015
Q3 		$2.14M Buy
25,908
+1,360
+6% +$118K ﹤0.01% 3347
2015
Q2 		$2.17M Buy
24,548
+4,268
+21% +$413K ﹤0.01% 3382
2015
Q1 		$1.79M Buy
+20,280
New +$1.89M ﹤0.01% 3455

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
MCM
Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group's EVGN Position: Q2 2019 in Review

Vanguard Group sold out of Evogene (EVGN) in Q2 2019, closing a stake of 6,352 shares — an estimated $116K sold.

Vanguard Group first reported a position in EVGN in Q1 2015 and held it in 17 quarters. The position peaked at $2.56M in Q3 2016. 18 funds tracked by Wall St. Rank hold EVGN as of Q2 2019.

  • Vanguard Group reported no remaining Evogene position as of Q2 2019 after selling out during the quarter.
  • Vanguard Group sold 6,352 Evogene shares in Q2 2019, an estimated $116K.
  • Vanguard Group first reported a position in Evogene in Q1 2015 and held it in 17 quarters.
  • Vanguard Group's Evogene position peaked at $2.56M in Q3 2016.
  • 18 funds tracked by Wall St. Rank held Evogene as of Q2 2019.

Based on Vanguard Group's 13F filing for Q2 2019, filed 14 Aug 2019.